Novel variants underlying autosomal recessive intellectual disability in Pakistani consanguineous families.
Child
Child, Preschool
Consanguinity
Family
Female
Genes, Recessive
/ genetics
Genetic Heterogeneity
Genetic Testing
Homozygote
Humans
Intellectual Disability
/ complications
Male
Membrane Proteins
/ genetics
Neurodevelopmental Disorders
/ complications
Pakistan
/ epidemiology
Pedigree
Polymorphism, Genetic
Vesicular Transport Proteins
/ genetics
Exome Sequencing
beta-Galactosidase
/ genetics
GLB1 gene
Intellectual disability
MLC1 gene
VPS53 gene
Whole exome sequencing
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
24 03 2020
24 03 2020
Historique:
received:
11
11
2019
accepted:
16
03
2020
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
6
5
2020
Statut:
epublish
Résumé
Intellectual disability (ID) is both a clinically diverse and genetically heterogeneous group of disorder, with an onset of cognitive impairment before the age of 18 years. ID is characterized by significant limitations in intellectual functioning and adaptive behaviour. The identification of genetic variants causing ID and neurodevelopmental disorders using whole-exome sequencing (WES) has proven to be successful. So far more than 1222 primary and 1127 candidate genes are associated with ID. To determine pathogenic variants causative of ID in three unrelated consanguineous Pakistani families, we used a combination of WES, homozygosity-by-descent mapping, de-deoxy sequencing and bioinformatics analysis. Rare pathogenic single nucleotide variants identified by WES which passed our filtering strategy were confirmed by traditional Sanger sequencing and segregation analysis. Novel and deleterious variants in VPS53, GLB1, and MLC1, genes previously associated with variable neurodevelopmental anomalies, were found to segregate with the disease in the three families. This study expands our knowledge on the molecular basis of ID as well as the clinical heterogeneity associated to different rare genetic causes of neurodevelopmental disorders. This genetic study could also provide additional knowledge to help genetic assessment as well as clinical and social management of ID in Pakistani families.
Sections du résumé
BACKGROUND
Intellectual disability (ID) is both a clinically diverse and genetically heterogeneous group of disorder, with an onset of cognitive impairment before the age of 18 years. ID is characterized by significant limitations in intellectual functioning and adaptive behaviour. The identification of genetic variants causing ID and neurodevelopmental disorders using whole-exome sequencing (WES) has proven to be successful. So far more than 1222 primary and 1127 candidate genes are associated with ID.
METHODS
To determine pathogenic variants causative of ID in three unrelated consanguineous Pakistani families, we used a combination of WES, homozygosity-by-descent mapping, de-deoxy sequencing and bioinformatics analysis.
RESULTS
Rare pathogenic single nucleotide variants identified by WES which passed our filtering strategy were confirmed by traditional Sanger sequencing and segregation analysis. Novel and deleterious variants in VPS53, GLB1, and MLC1, genes previously associated with variable neurodevelopmental anomalies, were found to segregate with the disease in the three families.
CONCLUSIONS
This study expands our knowledge on the molecular basis of ID as well as the clinical heterogeneity associated to different rare genetic causes of neurodevelopmental disorders. This genetic study could also provide additional knowledge to help genetic assessment as well as clinical and social management of ID in Pakistani families.
Identifiants
pubmed: 32209057
doi: 10.1186/s12881-020-00998-z
pii: 10.1186/s12881-020-00998-z
pmc: PMC7092478
doi:
Substances chimiques
MLC1 protein, human
0
Membrane Proteins
0
VPS53 protein, human
0
Vesicular Transport Proteins
0
GLB1 protein, human
EC 3.2.1.23
beta-Galactosidase
EC 3.2.1.23
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
59Références
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Front Pediatr. 2018 Dec 17;6:391
pubmed: 30631761
Hum Genet. 2018 Sep;137(9):735-752
pubmed: 30167849
Ann Neurol. 2014 Oct;76(4):473-83
pubmed: 25131622
Hum Genet. 2017 Jun;136(6):665-677
pubmed: 28349240
Pediatrics. 2014 Sep;134(3):e903-18
pubmed: 25157020
N Engl J Med. 2012 Nov 15;367(20):1921-9
pubmed: 23033978
Am J Hum Genet. 2001 Apr;68(4):831-8
pubmed: 11254442
Hum Mutat. 2003 Jun;21(6):577-81
pubmed: 12754702
Nature. 2011 Sep 21;478(7367):57-63
pubmed: 21937992
JIMD Rep. 2015;24:115-22
pubmed: 26108645
Neurology. 2010 Aug 24;75(8):718-25
pubmed: 20660364
EJIFCC. 2018 Apr 30;29(1):4-14
pubmed: 29765282
J Med Genet. 2014 May;51(5):303-8
pubmed: 24577744
Mol Psychiatry. 2017 Nov;22(11):1604-1614
pubmed: 27457812
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Mol Psychiatry. 2018 Apr;23(4):973-984
pubmed: 28397838
J Neurosci. 2013 Jun 19;33(25):10195-208
pubmed: 23785136
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Rev Genet. 2018 May;19(5):253-268
pubmed: 29398702
Orphanet J Rare Dis. 2016 May 04;11(1):57
pubmed: 27146152
Ann Neurol. 1995 Mar;37(3):324-34
pubmed: 7695231
Mol Biol Cell. 2000 Jan;11(1):305-23
pubmed: 10637310
Med Genet. 2018;30(3):323-327
pubmed: 30459488
Am J Hum Genet. 2016 Jan 7;98(1):149-64
pubmed: 26748517
Mol Psychiatry. 2019 Jul;24(7):1027-1039
pubmed: 29302074
Exp Cell Res. 2005 May 15;306(1):24-34
pubmed: 15878329